scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(70)91789-7 |
P698 | PubMed publication ID | 4192381 |
P2093 | author name string | H R Gralnick | |
P2860 | cites work | The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin | Q34297456 |
The mechanism of clot dissolution by plasmin | Q40330962 | ||
On the Quantitative Estimation of Prothrombin | Q47780898 | ||
New one-stage procedures for the quantitative determination of prothrombin and labile factor | Q47972843 | ||
Allwork SP: Fibrinolysis and bleeding in open-heart surgery. | Q54176648 | ||
Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease. | Q54525850 | ||
Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acid | Q72341448 | ||
Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy | Q72372191 | ||
An improved micro hematocrit method | Q73603655 | ||
Morphology and enumeration of human blood platelets | Q75602485 | ||
P433 | issue | 7658 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1204-1205 | |
P577 | publication date | 1970-06-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease. | |
P478 | volume | 1 |
Q93706191 | Anticoagulants in rheumatic heart-disease |
Q41546723 | Aspirin, thrombosis, and the future |
Q71656410 | Coagulation abnormalities in cyanotic heart disease |
Q33461237 | Consumption coagulopathy in congenital heart-disease |
Q93706193 | Correction of haemostatic defect in cyanotic congenital heart-disease |
Q39912829 | Disorders of Fibrinolysis |
Q44948870 | Dose comparison of tranexamic acid in pediatric cardiac surgery |
Q50474469 | Dynamics of factor XIII levels after open heart surgery for congenital heart defects: do cyanotic and acyanotic patients differ? |
Q73198465 | Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease |
Q41238758 | Excess intravascular coagulation complicating low cardiac output |
Q70599235 | Fibrinogen half-life in children with cyanotic congenital heart disease |
Q36763257 | Haemostatic defects in cyanotic congenital heart disease |
Q39919252 | Hematologic Effects of Cardiac Disease |
Q35314506 | Natural and synthetic antifibrinolytics in cardiac surgery |
Q68998780 | Preoperative evaluation of hemostasis in patients with congenital heart disease |
Search more.